Skip to main content

Advertisement

Log in

RETRACTED ARTICLE: High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC)

  • Research Article
  • Published:
Tumor Biology

Abstract

Recent studies have identified that ErbB3 binding protein 1 (EBP1) is broadly expressed in various cancer tissues and critically involved in plenty of biological processes in this regard. However, the functional role of EBP1 in pancreatic ductal adenocarcinoma (PDAC) has never been elucidated. In this study, we found that EBP1 could serve as a prognostic biomarker of PDAC. Western blot analysis revealed that EBP1 was remarkably upregulated in PDAC tissues and cell lines. Using immunohistochemical analysis, we showed that the expression of EBP1 was correlated with tumor size (P = 0.004), histological differentiation (P = 0.041), and tumor node metastasis (TNM) stage (P = 0.000). Notably, Kaplan–Meier curve showed that high expression of EBP1 predicted significantly worsened prognosis of PDAC patients (P = 0.001). In addition, knockdown of EBP1 expression suppressed PDAC cell proliferation and retarded cell cycle progression. Furthermore, depletion of EBP1 induced the apoptosis of Panc-1 cells. Of great interest, we found that EBP1 interacted with anti-apoptotic protein, Bcl-xL, and promoted its accumulation. In summary, our results suggest that EBP1 is a novel prognostic indicator and potential therapeutic target of PDAC, shedding new insights into the important role of EBP1 in cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Siegel R, Ma J, et al. Cancer statistics. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  2. Ryan DP, Hong TS, et al. Pancreatic adenocarcinoma. N Engl J Med. 2014;371:1039–49.

    Article  CAS  PubMed  Google Scholar 

  3. Costello E, Greenhalf W, et al. New biomarkers and targets in pancreatic cancer and their application to treatment. Nat Rev Gastroenterol Hepatol. 2012;9:435–44.

    Article  CAS  PubMed  Google Scholar 

  4. Yoo JY, Wang XW, et al. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br J Cancer. 2000;82:683–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Radomski N, Jost E. Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp Cell Res. 1995;220:434–45.

    Article  CAS  PubMed  Google Scholar 

  6. Xia X, Lessor TJ, et al. Analysis of the expression pattern of Ebp1, an ErbB-3-binding protein. Biochem Biophys Res Commun. 2001;289:240–4.

    Article  CAS  PubMed  Google Scholar 

  7. Liu Z, Ahn JY, et al. Ebp1 isoforms distinctively regulate cell survival and differentiation. Proc Natl Acad Sci. 2006;103:10917–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lessor TJ, Hamburger AW. Regulation of the ErbB3 binding protein Ebp1 by protein kinase C. Mol Cell Endocrinol. 2001;175:185–91.

    Article  CAS  PubMed  Google Scholar 

  9. Zhang Y, Woodford N, et al. Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases. Nucleic Acids Res. 2003;31:2168–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Squatrito M, Mancino M, et al. Ebp1 is a dsRNA-binding protein associated with ribosomes that modulates eIF2α phosphorylation. Biochem Biophys Res Commun. 2006;344:859–68.

    Article  CAS  PubMed  Google Scholar 

  11. Kim CK, Nguyen TLX, et al. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors. Cancer Res. 2010;70:9730–41.

    Article  CAS  PubMed  Google Scholar 

  12. Zhang Y, Linn D, et al. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance. Mol Cancer Ther. 2008;7:3176–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Sun J, Luo Y, et al. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance. BMC Cancer. 2012;12:499.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lessor TJ, Yoo JY, et al. Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines. J Cell Physiol. 2000;183:321–9.

    Article  CAS  PubMed  Google Scholar 

  15. Zhou H, Mazan-Mamczarz K, et al. Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer. Nucleic Acids Res. 2010;38:3619–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hu B, Xiong Y, et al. The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Mol Cell Biochem. 2014;396:175–85.

    Article  CAS  PubMed  Google Scholar 

  17. Liles JS, Arnoletti JP, et al. ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma. Cancer Biol Ther. 2010;10:555–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Reichert M, Saur D, et al. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res. 2007;67:4149–56.

    Article  CAS  PubMed  Google Scholar 

  19. Morton JP, Timpson P, et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci U S A. 2010;107:246–51.

    Article  CAS  PubMed  Google Scholar 

  20. Wan C, Hou S, et al. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability. Oncogene. 2013;34:237–45.

    Article  PubMed  Google Scholar 

  21. Moldovan GL, Pfander B, et al. PCNA, the maestro of the replication fork. Cell. 2007;129:665–79.

    Article  CAS  PubMed  Google Scholar 

  22. Liu Z, Oh SM, et al. Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. Mol Biol Cell. 2008;20:757–68.

    Article  PubMed  Google Scholar 

  23. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311–22.

    Article  CAS  PubMed  Google Scholar 

  24. Lamb J, Ramaswamy S, et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell. 2003;114:323–34.

    Article  CAS  PubMed  Google Scholar 

  25. Wolfgang CL, Herman JM, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318–48.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kim CK, Lee SB, et al. Long isoform of ErbB3 binding protein, p48, mediates protein kinase B/Akt-dependent HDM2 stabilization and nuclear localization. Exp Cell Res. 2012;318:136–43.

    Article  CAS  PubMed  Google Scholar 

  27. Ko HR, Kim CK, et al. Phosphorylation of the N-terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48. Molecular Carcinogenesis. 2014 n/a-n/a.

  28. Oh SM, Liu Z, et al. Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity. Oncogene. 2009;29:1017–30.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ko HR, Nguyen TL, et al. P42 Ebp1 functions as a tumor suppressor in non-small cell lung cancer. BMB Rep. 2014.

  30. Ahn JY, Liu X, et al. Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. EMBO J. 2006;25:2083–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Okada M, Jang SW, et al. Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis. J Biol Chem. 2007;282:36744–54.

    Article  CAS  PubMed  Google Scholar 

  32. Sengupta TK, Bose SK, et al. Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes. Biochem J. 2006;396:99.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Scientific Foundation of China (No. 81072028) and Jiangsu Province’s Outstanding Medical Academic Leader program (No. LJ101135).

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Guoxiong Zhou or Chunhua Wan.

Additional information

Chen Gong and Yixin Zhang contributed equally to this work.

The Publisher and Editor retract this article in accordance with the recommendations of the Committee on Publication Ethics (COPE). After a thorough investigation we have strong reason to believe that the peer review process was compromised.

Date: 16th June 2017

As an update to the retraction note, further investigation has revealed that the compromised peer review process was through no fault of the authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplemental Fig. 1

Graphic representation of the relationship between EBP1 and Ki-67 expression in 191 PDAC specimens. The scatter plots of EBP1 versus Ki-67 with regression line showing a correlation of them using the Spearman’s correlation coefficient. (GIF 15 kb)

(TIFF 171 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, C., Zhang, Y., Chen, Y. et al. RETRACTED ARTICLE: High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Tumor Biol. 36, 9189–9199 (2015). https://doi.org/10.1007/s13277-015-3625-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3625-6

Keywords

Navigation